EYPT:NASDAQ
EyePoint Inc
US$3.25
arrow_upward
+0.62%(+0.020) 1 天
10月2日, GMT-4 16:00:01 · USD
search
所有股票代码
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 EYPT 生成关键数据洞见…
开盘价
US$3.31
最高价
US$3.31
最低价
US$3.10
市值
2.80亿
平均成交量
395.08万
成交量
0.00
52 周最高价
US$19.01
52 周最低价
US$3.10
每股收益
-US$3.74
Beta 版
1.67
流通股数
8621.20万
员工人数
214
开盘价
US$3.31
最高价
US$3.31
最低价
US$3.10
市值
2.80亿
平均成交量
395.08万
成交量
0.00
52 周最高价
US$19.01
52 周最低价
US$3.10
每股收益
-US$3.74
Beta 版
1.67
流通股数
8621.20万
员工人数
214
新闻报道
来自网络来源和新闻合作伙伴
AD HOC NEWS
·
18小时前
EyePoint Pharmaceuticals stock holds at USD 3.25 after loss
Investor's Business Daily
·
1个月前
The Surprising Reason EyePoint Just Crashed 67%, Sacrificing A Breakout
资料
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc. Wikipedia
EyePoint Inc简介